Moderna’s Commitment to Transparency in Our Interactions with Healthcare Professionals, Healthcare Organizations, and Patient Advocacy Organizations
Collaboration between industry, healthcare professionals, healthcare organizations, and patient advocacy organizations is critical to the development and effective use of new vaccines and medicines. Moderna recognizes that transparent relationships with healthcare professionals and organizations are critical to our mission to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.
We are committed to complying with all applicable laws, regulations, and codes of conduct governing the transparency of our interactions with healthcare professionals and organizations to ensure public trust and confidence.
We publicly disclose the transfers of value made to healthcare professionals, healthcare organizations, and patient associations through applicable government portals and the Moderna website.
EFPIA DISCLOSURES 2021
On January 1, 2021 Moderna became a member of Vaccines Europe, a specialized vaccine industry group within EFPIA. As such, Moderna is committed to fully complying with the disclosure requirements of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Codes of Practice.
Please select the appropriate EFPIA country below to access the relevant disclosure reports and associated methodological notes for the period January 1, 2021- December 31, 2021.
United States Disclosure 2021
Moderna is required under the U.S. Physician Payments Sunshine Act to submit data related to payments and other transfers of value made to certain U.S. healthcare professionals and U.S. teaching hospitals to the Centers for Medicare and Medicaid Services (CMS) Open Payments program annually.